ASML vs ASRT · P/E 57, $665.37B cap vs rev $125.0M
ASML Holding NV ADR (ASML) versus Assertio Therapeutics Inc (ASRT) — a side-by-side from cached financials, not a winner call.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
ASML does not have a complete income-statement cache yet.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
ASML currently screens at market cap $665.37B and trailing P/E 57.5. ASRT currently screens at market cap $151.5M.
Not investment advice. Open the ASML and ASRT stock pages for the full models.
Not investment advice.